实验性肺炎克雷伯菌烧伤创面败血症：荚膜多糖的作用
Experimental Klebsiella pneumoniae burn wound sepsis: role of capsular polysaccharide.
作者信息
Cryz S J, Fürer F, Germanier R
出版信息
Infect Immun. 1984 Jan;43(1):440-1. doi: 10.1128/iai.43.1.440-441.1984.
Abstract
The role of Klebsiella pneumoniae capsular polysaccharide in relation to virulence in a murine burn wound sepsis model was investigated. Burn trauma markedly predisposed mice to lethal K. pneumoniae sepsis. A highly encapsulated variant (KP1-O) derived from K. pneumoniae KP1 was found to be extremely virulent for burned mice (50% lethal dose less than 10 organisms), whereas another variant (KP1-T), which possessed a much smaller capsule, was comparatively nonvirulent (50% lethal dose greater than 10(6) organisms). Production of large quantities of capsular material by KP1-O allowed for its rapid growth in vivo and persistence in the blood and liver. These traits were not demonstrated by KP1-T, which was effectively cleared after challenge.
摘要
研究了肺炎克雷伯菌荚膜多糖在小鼠烧伤创面脓毒症模型中与毒力的关系。烧伤创伤使小鼠极易发生致死性肺炎克雷伯菌脓毒症。从肺炎克雷伯菌KP1衍生出的一个高度荚膜化变体（KP1-O）对烧伤小鼠具有极强的毒力（半数致死剂量小于10个菌），而另一个荚膜小得多的变体（KP1-T）则相对无毒（半数致死剂量大于10⁶个菌）。KP1-O产生大量荚膜物质，使其能在体内快速生长并在血液和肝脏中持续存在。KP1-T则未表现出这些特性，在攻击后被有效清除。
相似文献
1
Experimental Klebsiella pneumoniae burn wound sepsis: role of capsular polysaccharide.
Infect Immun. 1984 Jan;43(1):440-1. doi: 10.1128/iai.43.1.440-441.1984.
2
Prevention of fatal experimental burn-wound sepsis due to Klebsiella pneumoniae KP1-O by immunization with homologous capsular polysaccharide.
J Infect Dis. 1984 Dec;150(6):817-22. doi: 10.1093/infdis/150.6.817.
3
Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide.
Infect Immun. 1984 Jul;45(1):139-42. doi: 10.1128/iai.45.1.139-142.1984.
4
Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae.
Infect Immun. 1982 Jul;37(1):327-35. doi: 10.1128/iai.37.1.327-335.1982.
5
Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence.
Can J Microbiol. 1985 May;31(5):472-8. doi: 10.1139/m85-088.
6
First two cases of severe multifocal infections caused by Klebsiella pneumoniae in Switzerland: characterization of an atypical non-K1/K2-serotype strain causing liver abscess and endocarditis.
J Glob Antimicrob Resist. 2017 Sep;10:165-170. doi: 10.1016/j.jgar.2017.04.006. Epub 2017 Jul 17.
7
Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice.
J Microbiol Biotechnol. 2010 May;20(5):935-41. doi: 10.4014/jmb.0909.09010.
8
Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae.
Infect Immun. 1995 Mar;63(3):847-52. doi: 10.1128/iai.63.3.847-852.1995.
9
Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055.
J Med Microbiol. 2011 Feb;60(Pt 2):205-210. doi: 10.1099/jmm.0.018580-0. Epub 2010 Oct 21.
10
Capsular Polysaccharide Types and Virulence-Related Traits of Epidemic KPC-Producing Klebsiella pneumoniae Isolates in a Chinese University Hospital.
Microb Drug Resist. 2017 Oct;23(7):901-907. doi: 10.1089/mdr.2016.0222. Epub 2017 Feb 24.
引用本文的文献
1
Combinatorial leaky probiotic for anticancer immunopotentiation and tumor eradication.
Cell Rep Med. 2024 Nov 19;5(11):101793. doi: 10.1016/j.xcrm.2024.101793. Epub 2024 Oct 22.
2
and as pathogens capable of causing co-infections and exhibiting similarities in their virulence factors.
Front Cell Infect Microbiol. 2022 Oct 20;12:991657. doi: 10.3389/fcimb.2022.991657. eCollection 2022.
3
A Molecular Interaction Map of and Its Human Host Reveals Potential Mechanisms of Host Cell Subversion.
Front Microbiol. 2021 Feb 18;12:613067. doi: 10.3389/fmicb.2021.613067. eCollection 2021.
4
Potential targets for next generation antimicrobial glycoconjugate vaccines.
FEMS Microbiol Rev. 2018 May 1;42(3):388-423. doi: 10.1093/femsre/fuy011.
5
Antibody-Mediated Killing of Carbapenem-Resistant ST258 by Human Neutrophils.
mBio. 2018 Mar 13;9(2):e00297-18. doi: 10.1128/mBio.00297-18.
6
The route less taken: pulmonary models of enteric Gram-negative infection.
Pathog Dis. 2014 Mar;70(2):99-109. doi: 10.1111/2049-632X.12109. Epub 2013 Nov 21.
7
Animal models of external traumatic wound infections.
Virulence. 2011 Jul-Aug;2(4):296-315. doi: 10.4161/viru.2.4.16840. Epub 2011 Jul 1.
8
Humoral immunity against capsule polysaccharide protects the host from magA+ Klebsiella pneumoniae-induced lethal disease by evading Toll-like receptor 4 signaling.
Infect Immun. 2009 Feb;77(2):615-21. doi: 10.1128/IAI.00931-08. Epub 2008 Nov 17.
9
Recognition of bacterial surface polysaccharides by lectins of the innate immune system and its contribution to defense against infection: the case of pulmonary pathogens.
Infect Immun. 2008 Apr;76(4):1322-32. doi: 10.1128/IAI.00910-07. Epub 2007 Dec 17.
10
Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development.
J Clin Microbiol. 2006 Jan;44(1):102-7. doi: 10.1128/JCM.44.1.102-107.2006.
本文引用的文献
1
Immunologic paralysis produced in mice by Klebsiella pneumoniae type 2 polysaccharide.
J Immunol. 1963 Jan;90:121-6.
2
The pathogenicity of Klebsiella pneumoniae for mice: the relationship to the quantity and rate of production of type-specific capsular polysaccharide.
J Bacteriol. 1956 Nov;72(5):713-7. doi: 10.1128/jb.72.5.713-717.1956.
3
Immunological paralysis induced in rabbits by a heavily capsulated Klebsiella strain.
Acta Pathol Microbiol Scand. 1956;38(5):375-84.
4
Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae.
Infect Immun. 1982 Jul;37(1):327-35. doi: 10.1128/iai.37.1.327-335.1982.
5
Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice.
Infect Immun. 1983 Mar;39(3):1067-71. doi: 10.1128/iai.39.3.1067-1071.1983.
6
Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966.
Medicine (Baltimore). 1969 Jul;48(4):307-32. doi: 10.1097/00005792-196907000-00003.
7
Burn wounds: microbiology, local host defenses, and current therapy.
CRC Crit Rev Clin Lab Sci. 1973 Jul;4(1):61-100. doi: 10.3109/10408367309151684.
8
Infections caused by Pseudomonas species in patients with burns and in other surgical patients.
J Infect Dis. 1974 Nov;130 Suppl(0):S8-13. doi: 10.1093/infdis/130.supplement.s8.
9
Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model.
J Infect Dis. 1975 Jun;131(6):688-91. doi: 10.1093/infdis/131.6.688.
10
Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: adenosine diphosphate ribosylation of elongation factor 2.
Infect Immun. 1978 Jan;19(1):29-33. doi: 10.1128/iai.19.1.29-33.1978.
Zotero 插件